Plain-English translation of NCT06945484 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This pilot study is testing a new approach called the Precision Exercise Regimen for Cancer Care (PERCC), which is a home-based exercise program delivered online with professional guidance. The program is designed for patients with stage II or stage III non-small cell lung cancer who are receiving chemotherapy or immunotherapy followed by surgery. Researchers want to see if exercising before, during, and after cancer treatment helps patients maintain their strength and physical function through this challenging time.
Many lung cancer patients become weaker during treatment, which can slow their recovery after surgery and affect their quality of life. This study exists to find out whether a personalized, remotely supervised exercise program can help prevent this weakness and keep patients stronger throughout their cancer care.
You likely qualify if…
You likely don't qualify if…
You would start the exercise program at least two weeks before your first cancer treatment and continue it through two months after your surgery. The program is done at home using a computer or device and includes a variety of exercises—like gentle movements, stretching, walking, and light strength training—that can be done lying down, sitting, standing, or walking, depending on what you're able to do. A trainer will supervise and guide you remotely throughout the entire time, adjusting the exercises as your treatment progresses and your body changes.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
United States
Sponsor
University of Utah
Enrollment target
~20 participants
Started
November 2025
Primary completion
January 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Thomas Varghese, MD, MS, MBA, FACS
Huntsman Cancer Institute/ University of Utah
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.